Asia-Pacific

Starting with a 2016 amendment to Korea’s Telecommunications Business Act, ISPs of comparable size have had to compensate each other based on the volume of traffic they exchange under a sending-party-network-pays policy. But consumers are the ones who ultimately pay in this arrangement.

With misguided localisation policies, Bangladesh's early progress and future promise are at risk. What path will Bangladesh's policymakers take as they conduct a final review of the country's Data Protection Act? The path to a false and costly promise of digital protectionism and control, or will they choose one that's based on targeted and balanced laws that reflect global data-policy norms that keep Bangladesh integrated with the global digital economy?

Crafting and implementing well-funded U.S. government policies that advance U.S. international competitiveness, especially in technology-driven industries and in relationship to China, requires a modicum of corporate political support or, at minimum, limited opposition.

In the last few years, a growing movement has advocated “responsible” technology development and use, particularly for artificial intelligence. The problem is that many of these efforts go beyond statements of generally agreed-upon principles and attempt to impose specific, elitist values and agendas on technology development.

For many years Korea had the honor of leading the world in industrial robot adoption. But that lead is now in doubt, as other nations, especially China, but also Japan and the United States, saw much faster increases in robot adoption in 2021, according to the International Federation of Robotics.

Stephen Ezell joins the program at HigherHeight 2022, hosted by Pfizer Indonesia and the Indonesian Biotechnology Study Program Association (IPSBI), to discuss what Indonesia can learn from Mexico’s experiences in building up its life sciences innovation ecosystem.

A strong dollar makes U.S. imports to Korea more expensive and Korean exports to the United States less expensive, which is great for American consumers but bad for American workers, and vice versa for Korea.

Stringent drug price controls have significantly hampered the competitive and innovative capacity of Japan’s biopharmaceutical industry in recent decades, serving as a warning for U.S. policymakers considering introducing Medicare Part D drug price controls in 2022.

ITIF's Daniel Castro is among the featured speakers for a July 12 webinar hosted by CUTS International to discuss gaps, unintended challenges, regulatory uncertainty, and the way forward for India's data-protection regime.

As the U.S. Congress hopefully finalizes a wide-ranging industrial policy legislative package, a number of pundits are pointing to Japan's economic performance as evidence that industrial policy is doomed to failure. But ITIF’s Hamilton Index tells a different story.